India, China set to dominate global generic market
Wednesday, 01 December 2010, 06:40 IST
Printer Print Email Email
Mumbai: India and China are all set to dominate the global generic (off-patent drugs) market as low manufacturing and R&D cost would prompt key pharma players to set up their base here, a report said. According to 'Health Paper', a report on the global generic market by industry body FICCI, low manufacturing and R&D cost in India and China as compared to other European markets will force most of the pharma players to shift their focus to these two countries. "...total manufacturing cost per unit in India is half compared to that of any European facility. Similarly, the R&D cost is substantially lower in India and China. This will force key pharma players to set up units here," it said.
Source: PTI
siliconindia